Cytokinetics
Price & Volume
Stats
See more52W Range | $29.31-$70.98 |
Market Cap | $7.8B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $87.2M |
Revenue Growth (YoY) | 318.1% |
Gross Profit (12 Mos) | -$318M |
Diluted EPS | -$6.30 |
News
See moreYahoo Finance • 4 days ago
Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Holley Inc. (NYSE: HLLY); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
Yahoo Finance • 6 days ago
Is First U.S. MYQORZO Approval Reshaping The Investment Case For Cytokinetics (CYTK)?
Yahoo Finance • 6 days ago
Weekly Buzz: CYTK Scores First FDA Approval, INSM Ends Rhinosinusitis Study, XOMA Acquires GBIO
Yahoo Finance • 7 days ago
Cytokinetics gains FDA approval of aficamten for hypertrophic cardiomyopathy
About
CEO | Mr. Robert I. Blum |
CFO | Mr. Sung H. Lee |
Address | 350 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 498 |
